JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

Search

ResMed Inc

Fechado

SetorSaúde

266.34 1.49

Visão Geral

Variação de preço das ações

24h

Atual

Mín

261.21

Máximo

268.23

Indicadores-chave

By Trading Economics

Rendimento

44M

393M

Vendas

87M

1.4B

P/E

Médio do Setor

25.197

84.243

Rendimento de Dividendos

0.87

Margem de lucro

27.593

Funcionários

10,600

EBITDA

63M

566M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+19.58% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.87%

2.28%

Próximos Ganhos

22 de abr. de 2026

Próxima data de dividendos

19 de mar. de 2026

Próxima data de ex-dividendo

12 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-107M

37B

Abertura anterior

264.85

Fecho anterior

266.34

Sentimento de Notícias

By Acuity

34%

66%

79 / 352 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

5 de fev. de 2026, 00:00 UTC

Ações em Alta

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4 de fev. de 2026, 22:55 UTC

Ganhos

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4 de fev. de 2026, 21:44 UTC

Ganhos

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4 de fev. de 2026, 21:39 UTC

Ganhos

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

5 de fev. de 2026, 00:00 UTC

Ganhos

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

5 de fev. de 2026, 00:00 UTC

Ganhos

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

4 de fev. de 2026, 23:46 UTC

Conversa de Mercado

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4 de fev. de 2026, 23:45 UTC

Ganhos

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4 de fev. de 2026, 23:32 UTC

Conversa de Mercado

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4 de fev. de 2026, 22:59 UTC

Aquisições, Fusões, Aquisições de Empresas

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4 de fev. de 2026, 22:30 UTC

Ganhos

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4 de fev. de 2026, 22:30 UTC

Ganhos

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4 de fev. de 2026, 22:21 UTC

Ganhos

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 de fev. de 2026, 22:17 UTC

Conversa de Mercado

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4 de fev. de 2026, 22:15 UTC

Conversa de Mercado

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4 de fev. de 2026, 22:00 UTC

Conversa de Mercado

ESG Roundup: Market Talk

4 de fev. de 2026, 21:53 UTC

Ganhos

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4 de fev. de 2026, 21:51 UTC

Ganhos

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

4 de fev. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Financial Services Roundup: Market Talk

4 de fev. de 2026, 21:50 UTC

Conversa de Mercado
Ganhos

Auto & Transport Roundup: Market Talk

4 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

4 de fev. de 2026, 21:45 UTC

Ganhos

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4 de fev. de 2026, 21:44 UTC

Ganhos

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4 de fev. de 2026, 21:43 UTC

Ganhos

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4 de fev. de 2026, 21:41 UTC

Ganhos

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 de fev. de 2026, 21:36 UTC

Conversa de Mercado

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4 de fev. de 2026, 21:30 UTC

Ganhos

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 de fev. de 2026, 21:30 UTC

Ganhos

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 de fev. de 2026, 21:30 UTC

Ganhos

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

19.58% parte superior

Previsão para 12 meses

Média 300.64 USD  19.58%

Máximo 345 USD

Mínimo 265 USD

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

13 ratings

8

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

79 / 352 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat